Melaseq-FFPE Validation Study Published

Multiple international studies have described the challenge of providing accurate and reproducible histopathological assessments of melanocytic lesions, highlighting the need for new diagnostic tools including disease-specific biomarkers.

In this study, Melaseq-FFPE (MEL38) expression in solid tissue biopsies representing the benign nevi to metastatic melanoma spectrum is examined.